press-releases
Lunaphore closes a CHF 23M Series C financing round
Date
Lunaphore Technologies SA, a Swiss life-sciences company developing innovative next-generation equipment for cancer research and tissue diagnostics, announces the first closing of its Series C funding, amounting to CHF 23M. The round was led by the Japanese strategic investor PHC Holdings Corporation, a global healthcare company that owns Epredia, a leading provider of comprehensive solutions for precision cancer diagnostics.